Table 3. Descriptive characteristics and levels of moderate-to-vigorous intensity physical activity and sedentary time in children with chronic respiratory diseases.
Reference* | Place and publication year | Sample group n, male% and age (yrs) |
Control group n, male% and age (yrs) |
Measurement | Accelerometry methods | MVPA | Sedentary time |
---|---|---|---|---|---|---|---|
Aznar et al [36] | Spain, 2014 | n: 47, (51% male) | n: 39; (59% male) | Actigraph GT3X, worn on right hip for 7 days during waking hours | Epoch = 15s, Evenson cut-point [30] | Patients mean 44 (SD 28) min/day | Patients mean 362 (SD 67) min/day |
Age: mean 12.0 (SD 3.0) | Age: mean 12.0 (SD 2.0) | MVPA ≥ 2296 cpm | Control group mean 54 (SD 15) min/day | Control group mean 484 (SD 85) min/day | |||
Sedentary time < 100 cpm | MVPA significantly lower in patient (p < 0.02) | Sedentary time was lower in patients (p < 0.001) | |||||
2% of patients and 34% of control group achieved an average 60 min/ day of MVPA | |||||||
Kilbride et al [37] | Ireland, 2012 | n: 16, (56% male) | n: 99, (48% male) | RT3 worn for 3 days | Epoch and MVPA cut-points not clearly reported | Patients mean boys 15 (SD 3); girls 16 (SD 3) min/day | N/A |
Age: range 10–12 | Age: range 10–12 | Sedentary time = 0–99cpm | Control group mean boys 23 (SD 6); girls 15 (SD 3) min/day | ||||
MVPA similar in patients and control group | |||||||
All patients failed to meet an average of 60 minutes/day MVPA | |||||||
Smith et al [38] | Germany, 2016 | n: 94, (56% male) | n: 590, (40% male) | Actigraph GT3X, worn on right hip for 7 days during waking hours | Epoch = 60s. Freedson cut-point [35] | Patients mean boys 41 (35) 11, 89; girls 43 (36) 14, 71 min/day | N/A |
Age: mean 15.6 (SD 0.5) | Age: mean 15.7 (SD 0.5) | Control group mean boys 46 (42) 19, 89; girls 38 (34) 13, 70 min/day | |||||
Tsai et al [39] | USA, 2012 | n: 27, (70% male) | n: 27, (59% male) | actigraph (Actiwatch 64 MM), worn non-dominant wrist for 7 days during waking hours | Epoch = 60s | Patients mean 265 (SD 83) min/day | Patients mean 87 (SD 48) min/day |
Age: range 9–11 | Age: range 9–11 | MVPA ≥ 700 cpm | Control group mean 308 (SD 97) min/day | Control group mean 77 (SD 27) min/day | |||
Sedentary time = 0–49 cpm | MVPA similar in patients and control group (p = 0.09) | Sedentary time difference not significant (p = 0.3) | |||||
Patients and control group achieved an average of 60 min per day of MVPA | |||||||
Vahlkvist et al [40] | Denmark, 2010 | n: 55 | n: 154 | RT3 worn for 4 weeks during 24 h a day | Epoch and cut-points not clearly reported | Patients mean of 32 (95% CI 5) min/day | Patients mean 1270 (95% CI 15) min/day |
Age: range 6–14 | Age: range 6–14 | Control group mean 34 (95% CI 3) min/day | Control group mean 1261 (95% CI 9) min/day | ||||
MVPA similar in patients and control group | Sedentary time was similar in patient and control group | ||||||
Patients and control group failed to achieve an average of 60 min per day of MVPA | |||||||
Van- Gent et al [41] | Netherlands, 2007 | n: 81, (58% male) | n: 202, (50% male) | Pam AM 100, worn on hip for 5 days during waking hours | Epoch = 60s | Patients mean 99 (95%, CI 80, 118) min/day | N/A |
Age: mean 9.4 (SD 0.8) | Age: mean 9.4 (SD 0.7) | MVPA cut-points not clearly reported | Control group mean 98 (95%, CI 85, 106) min/day | ||||
MVPA similar in patients and control group | |||||||
Patients and control group achieved an average of 60 min per day of MVPA | |||||||
Yiallouros et al [42] | Cyprus, 2015 | n: 36, (64% male) | n: 99, (60% male) | Actigraph worn on wrist for 7 days during waking hours | Epoch not clearly reported | Patients mean 15 (95% CI 10–21) min/day | Patients mean 939 (95% CI 915–963) min/day |
Age: range 8–9 | Age: range 8–9 | MVPA > 3200 cpm | Control group mean 16 (95% CI 14–19) min/day | Control group mean 927 (95% CI 915–938) min/day | |||
Sedentary time < 100 cpm | Similar in patients and control group | Similar in patients and control group |
cpm: counts per minutes; MVPA: moderate-to-vigorous physical activity; n: Number; S: Second; Data are expressed as mean (SD) unless otherwise in Smith et al [38]: MVPA calculated as mean (Geometric mean) 5th, 95th percentile, and Yiallouros et al [42]: MVPA Calculated as geometric means (95% CI) in min/day.; Freedson MVPA cutpoint [35] calculated using the following equation: METS = 2.757 + (0.0015 x counts/min)–(0.08957 x age (yr))–(0.000038 x counts/min x age (yr))
*Studies are recruited healthy control participants and measured MVPA and ST in the same way as in their patient participants and at the same time(referred to here as studies with control group).